Good morning.
The markets are never quiet, and especially not in earnings season—but things feel especially fidgety this week leading up to Fed Chair Jerome Powell’s tone-setting speech at Jackson Hole on Friday.
Terawulf $WULF is taking off, turbo-charged by headline after headline of breaking news. Some other key tech companies may be hitting buy zones, too.
And today’s partner wants to equip you with all the tools needed to get the most out of AI in your life.
In partnership with Outskill
Turn AI Into a $100K Income Before the Market Shifts (in just 16 hours)
The AI revolution is happening right before our eyes. From ChatGPT thriving with a $500B valuation to breakthrough AI tools transforming businesses, the way we work and earn is changing rapidly.
Here’s the truth: Every day you wait is money, time, and career potential lost. The future belongs to those who act fast, learn fast, and apply AI fast.
Invest your time in learning AI. Understand the tools, workflows, and use cases that are shaping the future of technology and business.
Join the World’s First 16-Hour LIVE AI Upskilling Sprint, designed to make you an AI Generalist who can build, automate, and monetize with AI. Register Now (Only 500 FREE seats left)
Date: Saturday and Sunday, 10 AM - 7 PM.
Rated 4.9/5 by global learners – this will truly make you an AI Generalist that can build, solve & work on anything with AI.
In just 16 hours & 5 sessions, you will:
✅ Master 10+ AI tools and LLM models to analyze markets, spot trends, and make data-driven investment decisions
✅ Build and ship AI-powered tools that accelerate research and automate financial workflows—in days instead of months
✅ Create AI agents that track stocks, crypto, and market news, freeing 20+ hours weekly
✅ Generate professional reports, visualizations, and insights for investing, trading, or consulting
✅ Turn your AI skills into $10K+ income via consulting, algorithmic trading, or AI-driven finance solutions
All by global experts from companies like Amazon, Microsoft, SamurAI and more. And it’s ALL. FOR. FREE. 🤯 🚀
Day 1: 3000+ Prompt Bible
Day 2: Roadmap to make $10K/month with AI
Bonus: Your Personal AI Toolkit Builder
Please support our partners!
📰 Market Headlines
Markets notched weekly wins on Friday as the Dow inched closer to its first record of the year, with major indexes weathering mixed economic signals and rate-cut uncertainty.
The Dow crept up 0.08%, the S&P 500 slipped 0.3%, and the Nasdaq dropped 0.4% after Trump announced semiconductor tariffs could arrive as soon as next week.
Terawulf $WULF is up almost 90% over the past 5 days, and it saw a huge amount of positive news just this morning—potentially setting it up to climb even higher in markets today. Here’s the rundown:
Google increased its stake in TeraWulf to 14%
Terawulf upped its total contracted capacity to 360+ MW of critical IT load
The company plans to offer $400 million of convertible senior notes in a private offering to institutional buyers
Tesla, Micron, and Applovin are all presenting potential buy ranges, according to analyst Ed Carson:
$TSLA looks like it's forming a potential cup and handle (his target entry @ $348.98). Carson raises the point that Tesla traders must rely on technical analysis, as earnings are set to fall for the 3rd year in a row. See AltIndex’s technical analysis of Tesla to compare.
$MU is forming another possible cup and handle formation—look for a target entry of $128.60 for confirmation, according to Carson.
And $APP cleared what seems to be a cup base last week—setting up for a high-handle entry point of $473.70 (which also functions as a “traditional handle to a broader six-month consolidation,” according to Carson).
Novo Nordisk $NVO popped 5% on news of its drug Wegovy gaining approval for use as a liver treatment. This is the first GLP-1 drug to be used for metabolic dysfunction-associated steatohepatitis (MASH) treatment.
Fed Chair Jerome Powell is set to give a market-defining speech of the year at Jackson Hole this Friday. Markets will be waiting with baited breath, as this annual speech is typically where Powell announces large changes in the Fed’s economic thinking for the year ahead. Leading up to the speech, markets have the odds of a September rate cut at about 83%.
Retail giants could cause turbulence or smooth sailing this week with incoming earnings from Home Depot, Lowe’s, Target, and Walmart. Investors are particularly interested in seeing how tariffs have affected them over the past three months. For context, 82% of S&P 500 companies who already reported this quarter have beaten Wall Street’s expectations (FactSet).
😱 Fear and Greed Index
🤖 AI/Future/Tech News
The U.S. Senate introduced the Chip Security Act, which would mandate Bond-style trackers and remote kill switches on advanced AI chips.
The GSA rolled out USAi, a secure GenAI suite for federal agencies to test AI tools.
🪙 Crypto
Wellgistics Health rolled out an XRP-powered payment system for 6,500 independent pharmacies.
Federal Reserve plans to scrap its dedicated program for policing banks' crypto and fintech activities.
Former SEC Commissioner Paul Atkins revealed the SEC is developing new crypto custody rules that could reshape institutional participation.
KindlyMD and Nakamoto Holdings completed their merger, creating a $700 million Bitcoin treasury.
In partnership with Lindy.ai
The Simplest Way To Create and Launch AI Agents
Imagine if ChatGPT and Zapier had a baby. That's Lindy. Build AI agents in minutes to automate workflows, save time, and grow your business.
Let Lindy's agents handle customer support, data entry, lead enrichment, appointment scheduling, and more while you focus on what matters most - growing your business.
Please support our partners!
🚨 Trending on Reddit
NVIDIA mentions are trending on r/WallStreetBets as investors question whether the AI giant's $4.4 trillion valuation makes sense with earnings approaching on August 27th.
UnitedHealth chatter is gaining traction after news that Warren Buffett, Michael Burry, and Marjorie Taylor Greene loaded up on shares. This odd trio of investors backing the same healthcare stock still has Reddit financial communities buzzing.
Intel discussions are hot on r/stocks after benchmarks leaked for their unannounced Lunar Lake chip.
🤫 Insider Trading
Stock | Who bought/sold? | Trade details | Total amount |
|---|---|---|---|
BLFS $BLFS | Casdin Partners Master Fund (10% Owner) | Proposed Sale 500,000 shares @ $25.32 on Aug 15 | $12,660,000 total |
LAB $LAB | Casdin Partners Master Fund (Director) | Bought 50,000 shares @ $1.22 on Aug 15 | $183,210 total |
📊 IPOs and Earnings
🎙 What Do You Think?
Will retailer earnings be good, bad, ugly, or middling?
🎤️ What you said last time
“I hear there's money in healthcare...”
🧠 The Missing (Market) Links
A crypto trader’s thoughts on why a 6- to 7-figure net worth is the most difficult amount of wealth to have in a bull market
Why the key to success in trading is appreciating what you have instead of a “never-enough” mindset
This couple took out a $1 million loan to save America's oldest drive-in theater.
Their business model? Generate $122K in July alone to carry the entire year's operations.
Seasonal business profits followed predictable patterns last year.
The drive-in theater turned profitable with $550K revenue but only $50K in net income after expenses, highlighting slim margins in entertainment venues.
Film licensing costs consumed a third of operating expenses for entertainment venues, according to one small business that finally broke even after two years of operation.
📊 Earnings
📜 Quote of the Day
“Someone's sitting in the shade today because someone planted a tree a long time ago.”
📢 We want to hear from you
We love hearing from you, and we deeply appreciate your feedback.
⭐️ What did you think of today's edition?
That’s all for today. Did I miss anything? Smash the reply button to let me know.
Cheers,
Brandon with Stefan & Wyatt
Thumbnail image credit: Mike Mozart, Flickr
The information provided in Stocks & Income is for informational and educational purposes only and should not be construed as financial advice, investment advice, or a recommendation to buy or sell any securities. Stocks & Income is not a registered investment advisor, broker-dealer, or licensed financial planner. Always do your own research and consult with a licensed financial advisor before making any investment decisions. We may hold positions in or receive compensation from the companies or products mentioned. Disclosures will be made where applicable.